Recalled batch for Clarithromycin 500 mg for Hameln Pharma Ltd
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Clarithromycin 500 mg Powder for concentrate for solution for infusion Clarithromycin Unregistered 24I243 Hameln Pharma Ltd
التصنيف
ملف
التاريخ
2026-01-01
اسم المستحضر
Clarithromycin 500 mg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of batch number 24I243 of Clarithromycin 500 mg due to non-compliance with the approved specifications, and the company's decision to withdraw it from the local market.
التوصيات
For healthcare professionals: Stop dispensing the above batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.